MIIM
PCRX icon

Mesirow Institutional Investment Management’s Pacira BioSciences PCRX Stock Holding History

Mesirow Institutional Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-248,687
Closed -$7.63M – 128
2023
Q3 		$7.63M Sell
248,687
-49,693
-17% -$1.79M 0.77% 73
2023
Q2 		$12M Buy
+298,380
New +$12.3M 1.23% 33
2022
Q4 		– Sell
-221,012
Closed -$11.8M – 124
2022
Q3 		$11.8M Buy
+221,012
New +$12.3M 1.7% 3

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Mesirow Institutional Investment Management's PCRX Position: Q4 2023 in Review

Mesirow Institutional Investment Management sold out of Pacira BioSciences (PCRX) in Q4 2023, closing a stake of 248,687 shares — an estimated $7.63M sold.

Mesirow Institutional Investment Management first reported a position in PCRX in Q3 2022 and held it in 3 quarters. The position peaked at $12M in Q2 2023. 261 funds tracked by Wall St. Rank hold PCRX as of Q4 2023.

  • Mesirow Institutional Investment Management reported no remaining Pacira BioSciences position as of Q4 2023 after selling out during the quarter.
  • Mesirow Institutional Investment Management sold 248,687 Pacira BioSciences shares in Q4 2023, an estimated $7.63M.
  • Mesirow Institutional Investment Management first reported a position in Pacira BioSciences in Q3 2022 and held it in 3 quarters.
  • Mesirow Institutional Investment Management's Pacira BioSciences position peaked at $12M in Q2 2023.
  • 261 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2023.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.